150 related articles for article (PubMed ID: 20135205)
1. Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin.
Choubey J; Bajpai AK
J Mater Sci Mater Med; 2010 May; 21(5):1573-86. PubMed ID: 20135205
[TBL] [Abstract][Full Text] [Related]
2. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate.
Bajpai AK; Choubey J
J Mater Sci Mater Med; 2006 Apr; 17(4):345-58. PubMed ID: 16617413
[TBL] [Abstract][Full Text] [Related]
3. Genipin-modified gelatin nanocarriers as swelling controlled drug delivery system for in vitro release of cytarabine.
Khan H; Shukla RN; Bajpai AK
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():457-65. PubMed ID: 26838872
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of DSBP from genipin-crosslinked gelatin thin films.
Abbasi A; Eslamian M; Heyd D; Rousseau D
Pharm Dev Technol; 2008; 13(6):549-57. PubMed ID: 18720250
[TBL] [Abstract][Full Text] [Related]
5. Hardly water-soluble drug-loaded gelatin nanoparticles sustaining a slow release: preparation by novel single-step O/W/O emulsion accompanying solvent diffusion.
Lee EJ; Lim KH
Bioprocess Biosyst Eng; 2017 Nov; 40(11):1701-1712. PubMed ID: 28791518
[TBL] [Abstract][Full Text] [Related]
6. Some physical and microstructural properties of genipin-crosslinked gelatin-maltodextrin hydrogels.
Nickerson MT; Farnworth R; Wagar E; Hodge SM; Rousseau D; Paulson AT
Int J Biol Macromol; 2006 Feb; 38(1):40-4. PubMed ID: 16443267
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of gelatin films by crosslinking with genipin.
Bigi A; Cojazzi G; Panzavolta S; Roveri N; Rubini K
Biomaterials; 2002 Dec; 23(24):4827-32. PubMed ID: 12361622
[TBL] [Abstract][Full Text] [Related]
8. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
9. Gelatin microspheres crosslinked with genipin for local delivery of growth factors.
Solorio L; Zwolinski C; Lund AW; Farrell MJ; Stegemann JP
J Tissue Eng Regen Med; 2010 Oct; 4(7):514-23. PubMed ID: 20872738
[TBL] [Abstract][Full Text] [Related]
10. A genipin-crosslinked gelatin membrane as wound-dressing material: in vitro and in vivo studies.
Chang WH; Chang Y; Lai PH; Sung HW
J Biomater Sci Polym Ed; 2003; 14(5):481-95. PubMed ID: 12807149
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of characteristics between glutaraldehyde- and genipin-crosslinked gelatin microspheres].
Li M; Liu X; Liu X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):87-91. PubMed ID: 19192887
[TBL] [Abstract][Full Text] [Related]
12. Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery.
Han S; Li M; Liu X; Gao H; Wu Y
Colloids Surf B Biointerfaces; 2013 Feb; 102():833-41. PubMed ID: 23107962
[TBL] [Abstract][Full Text] [Related]
13. Kinetic and mechanistic considerations in the gelation of genipin-crosslinked gelatin.
Nickerson MT; Patel J; Heyd DV; Rousseau D; Paulson AT
Int J Biol Macromol; 2006 Nov; 39(4-5):298-302. PubMed ID: 16797690
[TBL] [Abstract][Full Text] [Related]
14. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies.
Liang HC; Chang WH; Lin KJ; Sung HW
J Biomed Mater Res A; 2003 May; 65(2):271-82. PubMed ID: 12734822
[TBL] [Abstract][Full Text] [Related]
15. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
16. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
Ofokansi K; Winter G; Fricker G; Coester C
Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
[TBL] [Abstract][Full Text] [Related]
17. Effect of process variables on particle size and viability of Bifidobacterium lactis Bb-12 in genipin-gelatin microspheres.
Annan NT; Borza A; Moreau DL; Allan-Wojtas PM; Hansen LT
J Microencapsul; 2007 Mar; 24(2):152-62. PubMed ID: 17454426
[TBL] [Abstract][Full Text] [Related]
18. Crosslinking of gelatin-based drug carriers by genipin induces changes in drug kinetic profiles in vitro.
Thakur G; Mitra A; Rousseau D; Basak A; Sarkar S; Pal K
J Mater Sci Mater Med; 2011 Jan; 22(1):115-23. PubMed ID: 21107660
[TBL] [Abstract][Full Text] [Related]
19. [Study on the temporal change of properties of genipin crosslinked gelatin].
Jin X; Yan J; Zhou L; Ji Y; Yang X; Xu G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):150-3. PubMed ID: 18435279
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-Incorporated Nanotherapeutic Delivery System Based on Gelatin-Coated Gold Nanoparticles: Formulation, Drug Release, and Multimodal Imaging of Cellular Internalization.
Suarasan S; Focsan M; Potara M; Soritau O; Florea A; Maniu D; Astilean S
ACS Appl Mater Interfaces; 2016 Sep; 8(35):22900-13. PubMed ID: 27537061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
